Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Apr;215(4):356-62.
doi: 10.1097/00000658-199204000-00009.

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

P Damas  1 , D Ledoux, M Nys, Y Vrindts, D De Groote, P Franchimont, M Lamy
Affiliations

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

P Damas et al. Ann Surg. 1992 Apr.

Abstract

Forty critically ill surgical patients with documented infections were studied during their stay in an intensive care unit. Among these patients, 19 developed septic shock and 16 died, 9 of them from septic shock. Interleukin 1 beta (IL-1 beta), tumor necrosis factor (TNF alpha), and interleukin 6 (IL-6) were measured each day and every 1 or 2 hours when septic shock occurred. Although IL-1 beta was never found, TNF alpha was most often observed in the serum at a level under 100 pg/mL except during septic shock. During these acute episodes TNF alpha level reached several hundred pg/mL, but only for a few hours. In contrast, IL-6 was always increased in the serum of acutely ill patients (peak to 500,000 pg/mL). There was a direct correlation between IL-6 peak serum level and TNF alpha peak serum level during septic shock and between IL-6 serum level and temperature or C-reactive protein serum level. Moreover, IL-6 correlated well with APACHE II score, and the mortality rate increased significantly in the group of patients who presented with IL-6 serum level above 1000 pg/mL. Thus, IL-6 appears to be a good marker of severity during bacterial infection.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Clin Invest. 1988 Jun;81(6):1925-37 - PubMed
    1. Nature. 1987 Dec 17-23;330(6149):662-4 - PubMed
    1. Infect Immun. 1987 Jul;55(7):1622-5 - PubMed
    1. Science. 1986 Oct 24;234(4775):470-4 - PubMed
    1. Science. 1985 Aug 30;229(4716):869-71 - PubMed